Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	10/10/2008 6:45:42 AM
	Read Replies (1) of 10280

Susquehanna Upgrades Sepracor (SEPR) to Neutral October 9, 2008 7:56 AM EDT Susquehanna upgrades Sepracor Inc. (Nasdaq: SEPR) from Negative to Neutral. Susquehanna analyst says, "Today, we are taking an opportunity to update our financial forecasts to reflect current Rx trends. Our updated model reflects limited growth in Sepracor's major products (Xopenex HFA and Lunesta), but we are assuming a greater control in operating expenses for the remainder of 2008 and the out-years (2009-2012), as Lunesta television commercials are no longer omnipresent. Given the changes to our financial forecasts and more importantly the current valuation market of Sepracor, we are upgrading our rating to Neutral." Sepracor Inc. is a research-based pharmaceutical company engaged in the discovery, development and commercialization of differentiated products that are prescribed by primary care physicians and certain specialists.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next